43 44 ¶ These authors contributed equally 1 Author summary. 2 3 Prior to 2010, it was believed that the Madariaga virus (MADV) was primarily associated 4 with equine disease. However, an outbreak reported in Panama, in an endemic area where 5 Venezuelan equine encephalitis virus (VEEV) also circulates, suggested a change in its 6 epidemiological profile. We aimed to reconstruct the epidemiological dynamics of MADV 7 and VEEV, as well as additional alphaviruses known to circulate in the region in order to 8 understand MADV emergence. For this, cross-sectional serosurveys were used to 9 demonstrate that the Alphaviruses MADV, VEEV and Una virus have repeatedly infected 10 humans in eastern Panama over the past five decades. Whilst their historical transmission 11 has been low, we confirm that the transmission has recently increased for both MADV and 12 VEEV. 13 14 15 Abstract 16 Background. Madariaga virus (MADV), has recently been associated with severe human 17 disease in Panama, where the closely related Venezuelan equine encephalitis virus (VEEV) 18 also circulates. In June, 2017, a fatal MADV infection was confirmed in a community of 19 Darien province. 20 Methods. We conducted a cross-sectional outbreak investigation with human and 21 mosquito collections in July 2017, where sera were tested for alphavirus antibodies and 22 viral RNA. Additionally, by applying a catalytic, force-of-infection statistical model to two 23 serosurveys from Darien province in 2012 and 2017, we investigated whether endemic or 24 epidemic alphavirus transmission occurred historically. 25 Results. In 2017, MADV and VEEV IgM seroprevalence was 1.6% and 4.4%, respectively; IgG 26 antibody prevalences were MADV: 13.2%; VEEV: 16.8%; Una virus (UNAV): 16.0%; and 27 Mayaro virus (MAYV): 1.1%. Active viral circulation was not detected. Evidence of MADV 28 and UNAV infection was found near households -raising questions about its vectors and 29 enzootic transmission cycles. Insomnia was associated with MADV and VEEV infection, 30 depression symptoms were associated with MADV, and dizziness with VEEV and UNAV. 31 Force-of-infection analyses suggest endemic alphavirus transmission historically, with 32 recent increased human exposure to MADV and VEEV in some regions. 33 Conclusions. The lack of additional neurological cases suggest that severe MADV and VEEV 34 infections occur only rarely. Our results indicate that, over the past five decades, 35 alphavirus infections have occurred at low levels in eastern Panama, but that MADV and 36 VEEV infections have recently increased -potentially during the past decade. Endemic 37 infections and outbreaks of MADV and VEEV appear to differ spatially. 38 39
1 vegetation, from 18:00 to 06:00. Trapped mosquitoes were collected early in the morning 2 and placed in cryovials for storage in liquid nitrogen and transportation to the GMI. 3 Mosquitoes were maintained cold, sorted to species level using taxonomic keys [22] and 4 grouped into pools of 20 individuals. 5 6 Mosquito pools were homogenized in 2 mL of minimum essential medium supplemented 7 with penicillin and streptomycin, and 20% fetal bovine serum using a TissueLyser (Qiagen, 8 Hidden, Germany). After centrifugation of 12000 rpm for 10 mins, 200 μL of the 9 supernatant were inoculated in each of two 12.5-cm 2 flasks of Vero cells. Samples were 10 passaged twice for cytopathic effect (CPE) confirmation. The original mosquito suspensions 11 were used for RNA extraction and tested using alphavirus genus-specific RT-PCR [20] . 12 13 14 Statistical methods 15 16 Associated symptoms and risk factors analysis 17 We conducted separate analyses for MADV, VEEV and UNAV; in each case, the outcome 18 variable was the presence/absence of antibodies against the virus, as determined by a 19 PRNT 80 titre  1:20. The associations between each outcome and self-reported symptoms 20 in the last two weeks were tested using chi-squared and Fisher exact tests; p< 0.05 was 21 considered significant. The associations between each outcome and independent variables 22 were estimated using generalized estimating equations for logistic regression models [23] 23 and were expressed as Odds Ratios (ORs). The most parsimonious model was obtained with 24 log Likelihood Ratio Test (LRT) variable selection [24] . Univariable and multivariable ORs 25 were calculated with 95% confidence intervals. 26 27 Force-of Infection Analysis 28 To investigate the endemicity and/or recent emergence of three alphaviruses (VEEV, MADV 29 and UNAV), we combined age-structured sero-prevalence data from both surveys (i.e. from 30 2012 [8] and 2017), which encompassed seven sites (Pirre1-2 & Pijibasal, Mercadeo 31 Tamarindo, El Real, Aruza and Mogue) where either human or equine cases of VEEV or 32 MADV have occasionally been reported. See Figure 1 and supplementary materials for a 33 detailed description of these sites. 34 35 The historical force-of-infection (FOI) was estimated using a catalytic model [25] , where the 36 number of seropositive individuals in each sample was modelled using a binomial 37 distribution, 38
( , )~( , ( , )) 39 40 41 Here is the number of seropositive individuals and is the underlying ( , ) ( , ) 42 seroprevalence; in both cases, a denotes age and t denotes time; is sample size. By 43 making assumptions about (described below), we tested whether MADV, VEEV and ( , ) 44 UNAV transmission rate has historically been constant over time ("constant FOI'' model) or 1 has varied-for example, due to recent introduction of these viruses ("time-varying FOI'' 2 model). 3 4 For a constant FOI (λ), we modelled sero-prevalence for age in year (i.e. the time when 5 the sero-survey occurred) as, 6 7
( , ) = 1 -exp ( -). 8 9 For a time-varying FOI ( , we modelled sero-prevalence for age as, ) 10 11 12 13 14 15 In this framework, we assume no sero-reversion (loss of antibodies over time), no age 16 dependence in susceptibility or exposure [26] , and that mortality rate of infected 17 individuals is the same as for susceptible individuals. The models were estimated in a 18 Bayesian framework using Stan's No-U-Turn Sampler [27, 28] . Details of priors and model 19 simulations and packages used are provided in Supplementary Materials. Median of the 20 posteriors distribution of the parameters and their corresponding 95% Credible Intervals 21 (95%CrI) are presented. 22 23 24 Ethics 25 The outbreak investigation was undertaken during a public health outbreak response and 26 Ethical approval for use of surveillance data and cross-sectional surveys was given by the 27 GMI Ethics Committee (IRB # 0277/CBI/ICGES/15 and IRB # 047/CNBI/ICGES/11). The 28 written informed consent of participants was obtained. All identifying information of 29 participants was removed and confidentiality was strictly respected. The animal component 30 of this study was approved by the GMI Committee of Care and Use of Animals (001/05 31 CIUCAL / ICGES, July 4, 2005) , and conducted in accordance with Law number 23 of 32 January 15, 1997 (Animal Welfare Guarantee) of the Republic of Panama. 33 34 RESULTS 35 Characteristics of the study population 36 In 2017, 250 participants belonging to 59 houses were surveyed, with complete risk factor 37 data available for only 243 individuals (97.2%). Ages ranged from 1-97 years, and females 38 comprised 51% of surveyed individuals. Further characteristics of the surveyed population 39 are given in Table 1 . 40 1 In 2012, a total of 826 participants was surveyed, but only 774 sera were available for 2 laboratory testing. The risk factors determined from this sero-survey have previously been 3 published [8] . 4 5 Alphavirus detection and seroprevalence in 2012 and 2017 6 In 2012, the overall neutralising antibody seroprevalence was 4.8% (95% CI: 3.4-6.5%) for 7 MADV, and 31.6% (95% CI: 28.3-35.0%) for VEEV. 8 9 In 2017, the overall neutralising antibody seroprevalence was: MADV: 13.2% (95% CI 9.2-10 18.0%); VEEV: 16.8% (95% CI 12.4-22.0%); UNAV: 16.0% (95% CI 11.7-21.1%); and MAYV: 11 1.2% (95% CI 0.3-3.5%). No evidence of CHIKV infection was found. Neutralising antibody 12 seroprevalence to more than one virus were observed in 3.6% (95% CI 1.6-6.7%) of 13 participants. The proportion of subjects with both MADV and VEEV antibodies was 3.7% 14 (df= 1 ; Pearson chi2= 3.43;test for independence P= 0.064); both UNAV and VEEV 15 antibodies 3.7% (df=1; Pearson chi2=0.91; test for independence P=0.340) and both MADV 16 and UNAV antibodies 2.9% (df=1; Pearson Chi2= 0.97; test for independence P= 0.325). 17 Only one subject presented antibodies against these three viruses. IgM prevalence was: 18 MADV 1.6% (95% CI 0.4-4.2%); and VEEV 4.4% (95% CI 2.2-7.8%). Concurrent MADV and 19 VEEV IgM was observed in 0.8% of individuals (95% CI 0.1-2.9%). Viral RNA was not 20 detected in sera. 21 22 Associated symptoms and risk factors 23 Exposure to MADV was significantly associated with self-reported dizziness, fatigue, 24 depression, and difficulty cooking. Having VEEV neutralising antibodies was associated with 25 dizziness and insomnia (Table 2) . Participants over 11 years of age were more likely to test 26 positive for UNAV antibodies, with those over 30 years of age being the most likely (Tables  27 3 and 4 ). Having a house with walls reduced the risk of testing positive for UNAV antibodies 28 (Tables 3 and 4 ). The most parsimonious multivariable model revealed that being older and 29 having vegetation around the house were positively associated with MADV antibody 30 prevalence (Table 4 ). Washing clothes in ravines or rivers was also positively associated 31 with VEEV antibodies in the multivariable model (Table 4) . Figure 4 ). The highest estimated 7 sero-prevalence of each of the three viruses in under-10-year-olds (an indirect metric of 8 recent transmission) were estimated for VEEV in Pirre 1-2 & Pijibasal at a posterior median 9 of 44.8% (95%CrI: 34.9-55.0%) , followed by UNAV in Mogue at 5.6% (95%CrI: 4.1 -7.5) 10 and by MADV in Aruza at 4.7% (95%CrI: 3.2-6.7%). 11 12 For MADV, in six of the seven locations, there was no evidence of time-varying transmission 13 ( Table 5 ); but in one location, Aruza, FOI was estimated as 0.012 (CrI95% 0.006 -0.021) 14 (Figure 2A (Table 5) . For the constant model, we estimated an annual FOI of 0.08 20 (95%CrI, 0.06 -0.11) for VEEV in Pirre 1-2 & Pijibasal corresponding, to seroprevalence 21 reaching 75% in 15-year-olds and almost 100% by 60 years of age ( Figure 3A ). However, 22 from the relatively small sample (only 75 subjects), it is unclear whether these results are 23 due to consistently high endemic transmission or recent introductions and/or recent 24 outbreaks. For one location, Mercadeo, a time-varying FOI model fit the data best. In this 25 case, FOI in the most recently analyzed decade (2002-2012) was estimated at 0.04 (95%CrI: 26 0.03 -0.06) -an increase of 1.5 times (ratio of posterior medians) over the previous 27 decade (1992-2012) and 3.1 times that of 1972-1992 ( Figure 3B ). 28 29 For UNAV, only tested in Mogue, a constant model fit the data best with a FOI estimated at 30 0.008 (95% CrI: 0.006-0.011) ( Figure 4 ). 31 32 Discussion 33 34 By analyzing data from recent cross-sectional seroprevalence studies, we reconstructed 35 alphavirus transmission in eastern Panama. Historical transmission rates indicated endemic 36 transmission of VEEV, MADV and UNAV in humans with increased human exposure during 37 the past decade. Here, we show evidence of acute IgM antibody responses against MADV 38 and VEEV in people without signs of neurologic disease, suggesting asymptomatic 39 infections or mild disease. To our knowledge, this is the first evidence of human infection 40 with UNAV in Panama, even though its circulation was reported during the 1960s in 41 mosquitoes (Psorophora ferox and Ps. albipes) collected in western Panama [17] . Our 42 results also demonstrate the highest seroprevalence of UNAV reported in Latin 43 America [15, 29] . 44 1 Using catalytic FOI models fit to age-stratified seroprevalence data, we reconstructed 50 2 years of historical transmission rates for VEEV and MADV for seven locations in Darien 3 Province. In most locations, the data indicated consistent endemic transmission of these 4 viruses. In two locations -Mercadeo (for VEEV) and Aruza (for MADV) -there was 5 evidence of a recent increase in human exposure. These results suggest that MADV and 6 VEEV incidence differ geographically. The observed FOI profile suggest that VEEV infections 7 increased in Pirre 1-2 & Pijibasal and Mercadeo, locations surrounded by tropical forest, 8 while MADV infections increased mostly in Aruza, a formerly forested area converted to 9 agricultural land over 30 years ago [30] . Although ecological changes could be associated 10 with the increased exposure to MADV in Aruza, it is unclear which drivers could also explain 11 the simultaneous rise in VEEV we estimated. 12 13 14 Only 3.6% of participants had antibodies to more than one alphavirus. Mixed alphavirus 15 antibody responses in Peru [5] and Panama [8] suggest cross-protective immunity. However, 16 the mechanism of cross-protection and whether some alphaviruses induce a stronger 17 heterologous response than others remain unclear. 18 19 The MADV seroprevalence in 2017 was greater for those living with vegetation around the 20 house, contrasting with previous evidence in 2012, suggesting possible change in exposure 21 risk [8] . However, characteristics of houses in Mogue in 2017 may differ from areas that 22 were surveyed in 2012 [8] . Potential MADV vectors within the Culex (Melanoconion) 23 subgenus[31] were found during our peridomestic investigation in Mogue. This finding of 24 vectors near houses with surrounding vegetation as a risk factor supports the hypothesis 25 that MADV infections can occur near houses. This contrasts with VEEV risk factors, which 26 include washing clothes in ravines or rivers, suggesting that VEEV seropositivity is 27 associated with human incursion into the gallery forest, a potential natural habitat for 28 development of larvae of the main vectors Culex (Melanoconion) spp [31] . 29 30 Having a house with walls was associated with lower UNAV sero-prevalence in Mogue. This 31 suggests that UNAV infections can also occur outside of the forest, where the main vector 32 Ps. ferox and non-human primates are believed to maintain the enzootic cycle [16, 17, 19] . 33 Psorophora spp. have been also found in disturbed areas of Panama[32], indicating 34 potential changes in the vector habitat usage. 35 36 Alphaviral exposure was associated with several self-reported neurological and 37 constitutional sequelae. Specifically, weakness, insomnia, depression and dizziness were 38 commonly associated with prior MADV, VEEV, and UNAV exposure. Depression and other 39 neurological symptoms have also been observed after neurotropic flavivirus infections in 40 North America [33] . However, the role of several alphaviruses in long-term neurological 41 impairment is still unknown. This highlights the need to further investigate the long term 42 ramifications of alphaviral infection with objective testing (e.g. neuropsychological testing, 43 imaging) . 44 1 Alphaviral RNA was not detected in samples from either humans or mosquitoes, even 2 though field surveys and collection were performed soon after the confirmation of a fatal 3 MADV infection in the community. Although sample size is always a limiting factor in 4 attempts to identify ongoing infections, these results suggest that these alphaviruses may 5 be short-lived peripherally, or produce low viremia [7] . Low MAYV sero-prevalence was also 6 detected in our earlier research[7], indicating little human exposure to this virus in Panama. 7 8 Our study has several limitations. Clinical outcomes statistically associated to exposure to 9 these alphaviruses represent exploratory, and causal inference studies that should be 10 followed up with more comprehensive assessments. Our study only obtained preliminary 11 data during an outbreak response to generate hypotheses. Although mosquito collections 12 were only performed over two days, and the number of collected mosquitos does not allow 13 us to draw conclusions about active viral circulation. The collection of few mosquitos 14 vectors near houses suggest close contact between vectors and humans. The use of both 15 CDC traps baited with octanol and Trinidad traps enhanced our ability to captured 16 alphavirus enzootic vectors [34] . The sample size used in these sero-surveys only allowed 17 us to describe general trends in the force-of-infection over time. Also, we cannot exclude 18 cross-reactivity or age-dependency in exposure or susceptibility. More precise estimates 19 would require an increased sample size and, ideally, longitudinal data collection. 20 21 In summary, we investigated alphavirus transmission in Panama using age-specific 22 seroprevalence data to look back over five decades . Our results suggest that human 23 alphavirus infections may have gone undetected by the Panamanian surveillance system, 24 and hint that the MADV and VEEV outbreaks in 2010 may have been due to a common 25 increase in enzootic circulation. The antibody seroprevalence we determined for UNAV is 26 the highest reported in Latin America. Taken together, these results coupled with potential 27 symptoms of MADV and VEEV infection underscore the importance of developing 28 comprehensive arboviral surveillance in Latin American enzootic regions. 
